Semin intervent Radiol 2022; 39(01): 066-074
DOI: 10.1055/s-0042-1742381
Review Article

Devices and Techniques for Percutaneous Creation of Dialysis Arteriovenous Fistulas

Ahmed Kamel Abdel Aal
1   University of Texas Health Science Center at Houston, Department of Radiology, Houston, Texas
,
Xavier Jefferson
2   Baylor College of Medicine, Houston, Texas
,
Carleigh Klusman
2   Baylor College of Medicine, Houston, Texas
,
Laurynn Garcia
2   Baylor College of Medicine, Houston, Texas
,
Haydi Hassanein
3   University of Missouri, Columbia, Missouri
,
Talal Abdel Aal
4   Washington University, Saint Louis, Missouri
,
Mohamed M. Shahin
1   University of Texas Health Science Center at Houston, Department of Radiology, Houston, Texas
› Author Affiliations

Abstract

Dialysis treatment for chronic kidney disease was first developed by Dr. Willem Kolff in 1943, and its availability began to grow in 1962 after which it has become a mainstay treatment for patients with chronic kidney disease. It is estimated that, in 2021, 15% of adults in the United States (∼37 million people) have chronic kidney disease, of which 661,000 individuals have renal failure, and 468,000 individuals require dialysis. There have been several advancements in dialysis treatment since its advent, most notably the creation of arteriovenous fistulas (AVFs) for venous access in 1966. In recent years, the U.S. Food and Drug Administration approved two new devices for AVF creation using a percutaneous approach. These are the WavelinQ (Becton Dickinson, New Jersey) and the Ellipsys (Avenu Medical, California) endovascular AVF (endoAVF) devices that use radiofrequency and thermal technologies, respectively, to create the AVF. Since the introduction of these technologies, several studies have shown that they are safe and effective, with favorable durability and low rate of serious adverse events. In this article, we will discuss these two devices and the techniques used for percutaneous creation of dialysis AVF as an alternative to traditional open surgical techniques.



Publication History

Article published online:
18 February 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Arteriovenous Fistulas. Radiologykey.com. Published June 30, 2019. Accessed November 15, 2021
  • 2 Bracamonte H. A brief history of dialysis. Dpcedcenter.org. Published March 10, 2016. Accessed November 15, 2021
  • 3 Chronic kidney disease in the United States, 2021. Cdc.gov. Published March 9, 2021. Accessed November 15, 2021
  • 4 Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2021. Centers for Disease Control and Prevention, US Department of Health and Human Services; 2021
  • 5 United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2020
  • 6 Al-Jaishi AA, Oliver MJ, Thomas SM. et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 2014; 63 (03) 464-478
  • 7 Rajan DK, Ebner A, Desai SB, Rios JM, Cohn WE. Percutaneous creation of an arteriovenous fistula for hemodialysis access. J Vasc Interv Radiol 2015; 26 (04) 484-490
  • 8 Lok CE, Rajan DK, Clement J. et al; NEAT Investigators. Endovascular proximal forearm arteriovenous fistula for hemodialysis access: results of the prospective, multicenter Novel Endovascular Access Trial (NEAT). Am J Kidney Dis 2017; 70 (04) 486-497
  • 9 Radosa CG, Radosa JC, Weiss N. et al. Endovascular creation of an arteriovenous fistula (endoAVF) for hemodialysis access: first results. Cardiovasc Intervent Radiol 2017; 40 (10) 1545-1551
  • 10 Jones RG, Morgan RA. A review of the current status of percutaneous endovascular arteriovenous fistula creation for haemodialysis access. Cardiovasc Intervent Radiol 2019; 42 (01) 1-9
  • 11 Wasse H, Alvarez AC, Brouwer-Maier D. et al. Patient selection, education, and cannulation of percutaneous arteriovenous fistulae: an ASDIN White Paper. J Vasc Access 2020; 21 (06) 810-817
  • 12 Hull JE, Jennings WC, Cooper RI, Waheed U, Schaefer ME, Narayan R. The pivotal multicenter trial of ultrasound-guided percutaneous arteriovenous fistula creation for hemodialysis access. J Vasc Interv Radiol 2018; 29 (02) 149-158.e5
  • 13 Jennings WC, Mallios A, Mushtaq N. Proximal radial artery arteriovenous fistula for hemodialysis vascular access. J Vasc Surg 2018; 67 (01) 244-253
  • 14 Beathard GA, Lok CE, Glickman MH. et al. Definitions and end points for interventional studies for arteriovenous dialysis access. Clin J Am Soc Nephrol 2018; 13 (03) 501-512
  • 15 Toledo-Pereyra LH, Kyriakides GK, Ma KW, Miller J. Proximal radial artery-cephalic vein fistula hemodialysis. Arch Surg 1977; 112 (02) 226-227
  • 16 Mallios A, Jennings WC, Boura B, Costanzo A, Bourquelot P, Combes M. Early results of percutaneous arteriovenous fistula creation with the Ellipsys vascular access system. J Vasc Surg 2018; 68 (04) 1150-1156
  • 17 Hull JE, Elizondo-Riojas G, Bishop W, Voneida-Reyna YL. Thermal resistance anastomosis device for the percutaneous creation of arteriovenous fistulae for hemodialysis. J Vasc Interv Radiol 2017; 28 (03) 380-387
  • 18 Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol 2006; 17 (05) 807-813
  • 19 Shahverdyan R, Beathard G, Mushtaq N, Litchfield TF, Nelson PR, Jennings WC. Comparison of outcomes of percutaneous arteriovenous fistulae creation by Ellipsys and WavelinQ Devices. J Vasc Interv Radiol 2020; 31 (09) 1365-1372
  • 20 Yang S, Lok C, Arnold R, Rajan D, Glickman M. Comparison of post-creation procedures and costs between surgical and an endovascular approach to arteriovenous fistula creation. J Vasc Access 2017; 18 (Suppl. 02) 8-14